Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Therapeutic Advances in Respiratory Disease|September 15, 2018
New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1Nicolas Villanueva, Lyudmila BazhenovaLung Cancer (Auckland, N.Z.)|April 1, 2021
Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)Nicholas Giustini, Lyudmila BazhenovaBMJ Case Reports|May 8, 2023
Metastatic HER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecanKaren M Yun, Lyudmila BazhenovaCancers|April 13, 2024
Emerging New Targets in Systemic Therapy for Malignant Pleural MesotheliomaKaren M Yun, Lyudmila BazhenovaClinical Advances in Hematology & Oncology : H&O|March 3, 2023
Management of toxicities associated with immune checkpoint inhibitorsKaren M Yun, Lyudmila BazhenovaThoracic Surgery Clinics|April 25, 2020
ROS1-rearranged Non-small Cell Lung CancerNicholas P Giustini, Lyudmila BazhenovaLeukemia & Lymphoma|December 3, 2005
Intravascular lymphoma: a role for single-agent rituximabLyudmila Bazhenova, Philip Higginbottom, James MasonTranslational Cancer Research|January 9, 2026
Targeting MET in advanced and metastatic non-small cell lung cancer: a literature review of the current landscapeAmanda Herrmann, Christopher Grant, Lyudmila BazhenovaExpert Opinion on Pharmacotherapy|July 6, 2021
An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancerShiruyeh Schokrpur, Van Hilburn, Nicholas Giustini, et al.Cancers|December 11, 2025
Circulating Biomarkers and Targeted Therapy in Pleural MesotheliomaChristopher R Grant, Lyudmila Bazhenova, Karen M YunPageof 11